Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-18

Clinical Trial Update: Serum Irisin in Myocardial Infraction and Following Percutaneous Coronary Intevention [NA]

View source ↗

Summary

A completed clinical trial investigating serum irisin levels in patients with myocardial infarction and after percutaneous coronary intervention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: 424 General Military Hospital | Conditions: Myocardial Infarction, Coronary Artery Disease | NA | Status: COMPLETED